Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_assertion type Assertion NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_head.
- NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_assertion description "[Expression of RALDH2 and RDH10 was conserved in 100 % of adenomas and in 90 and 98 %, respectively, of carcinomas, whereas staining for CRBP1 was decreased in 9 % of FAs and 28 % of carcinomas, mainly anaplastic carcinomas (55 %).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_provenance.
- NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_assertion evidence source_evidence_literature NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_provenance.
- NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_assertion SIO_000772 23639973 NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_provenance.
- NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_assertion wasDerivedFrom befree-20150227 NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_provenance.
- NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_assertion wasGeneratedBy ECO_0000203 NP668014.RAcG6bDSqXzEYV6PjhKs9Mea_ARlwmDU_dGIwOIDp4z8I130_provenance.